| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 17,753 | 9,601 | ||
| Short-term investments | 14,157 | 25,168 | ||
| Restricted cash | 784 | 784 | ||
| Prepaid expenses and other current assets | 2,912 | 2,783 | ||
| Total current assets | 35,606 | 38,336 | ||
| Property and equipment, gross | 8,632 | - | ||
| Less accumulated depreciation and amortization | 7,132 | - | ||
| Property and equipment, net | 1,500 | 1,718 | ||
| Operating lease right-of-use assets | 19,881 | 20,517 | ||
| Restricted cash, non-current | 981 | 981 | ||
| Long-term investments | 6,906 | 13,725 | ||
| Other assets | 179 | 222 | ||
| Total assets | 65,053 | 75,499 | ||
| Accounts payable | 1,518 | 1,852 | ||
| Accrued expenses and other current liabilities | 3,839 | 5,387 | ||
| Deferred revenue | 1,909 | 2,512 | ||
| Operating lease liabilities | 2,700 | 2,559 | ||
| Total current liabilities | 9,966 | 12,310 | ||
| Operating lease liabilities, net of current portion | 20,889 | 21,624 | ||
| Deferred revenue, non-current | 1,964 | 2,590 | ||
| Other long-term liabilities | 133 | 133 | ||
| Total liabilities | 32,952 | 36,657 | ||
| Additional paid-in capital | 486,259 | 485,852 | ||
| Accumulated other comprehensive (loss) gain | -10 | -6 | ||
| Accumulated deficit | -454,148 | -447,004 | ||
| Total stockholders' equity | 32,101 | 38,842 | ||
| Total liabilities and stockholders' equity | 65,053 | 75,499 | ||
Bolt Biotherapeutics, Inc. (BOLT)
Bolt Biotherapeutics, Inc. (BOLT)